Executive Briefings | April 21, 2014
Parity Is A Great Leap Forward – But What Is The Next Step?
A few weeks ago, my colleague Laura Morgan wrote about the estimates of the effects of parity on spending and utilization for addiction treatment (see Parity When All Things Aren’t Equal). An important takeaway from her analysis was that a key variable in utilization is how payers (employers, managed care organizations, insurers, etc.) choose to manage their addiction treatment benefit in terms of fees and the definitions of medical necessity and clinical appropriateness. A recent HealthAffairs Health Policy Brief, <a href="http . . .